{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:32:19Z","timestamp":1766158339962,"version":"3.48.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"DOI":"10.7759\/cureus.99628","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:24:08Z","timestamp":1766157848000},"source":"Crossref","is-referenced-by-count":0,"title":["Health Disparities Among Children Who Are HIV-Exposed but Without HIV: A Narrative Literature Review and Call to Action for Further Research"],"prefix":"10.7759","author":[{"given":"Amy","family":"Parnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Moorhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecelia","family":"Hutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M","family":"Powis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M","family":"Puga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30448-6","article-title":"Estimates of the global population of children who are HIV-exposed and uninfected, 2000-18: a modelling study","volume":"8","author":"Slogrove AL","year":"2020","unstructured":"Slogrove AL, Powis KM, Johnson LF, Stover J, Mahy M. Estimates of the global population of children who are HIV-exposed and uninfected, 2000-18: a modelling study. Lancet Glob Health. 2020, 8:e67-75. 10.1016\/S2214-109X(19)30448-6","journal-title":"Lancet Glob Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5076","article-title":"Antiretroviral treatment of HIV\/AIDS during pregnancy","volume":"329","author":"Eke AC","year":"2023","unstructured":"Eke AC, Lockman S, Mofenson LM. Antiretroviral treatment of HIV\/AIDS during pregnancy. JAMA. 2023, 329:1308-9. 10.1001\/jama.2023.5076","journal-title":"JAMA"},{"key":"ref3","unstructured":"Preventing Perinatal Transmission of HIV. (2023). Accessed. August 20, 2025: https:\/\/www.hiv.gov\/hiv-basics\/hiv-prevention\/reducing-mother-to-child-risk\/preventing-mother-to-child-transmission-o...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1670-9","article-title":"Prevention of mother-to-child transmission of HIV and paediatric HIV care and treatment monitoring: from measuring process to impact and elimination of mother-to-child transmission of HIV","volume":"21","author":"Idele P","year":"2017","unstructured":"Idele P, Hayashi C, Porth T, Mamahit A, Mahy M. Prevention of mother-to-child transmission of HIV and paediatric HIV care and treatment monitoring: from measuring process to impact and elimination of mother-to-child transmission of HIV. AIDS Behav. 2017, 21:23-33. 10.1007\/s10461-016-1670-9","journal-title":"AIDS Behav"},{"key":"ref5","unstructured":"UNAIDS AIDSinfo. Global Data on HIV Epidemiology and Response. (2025). Accessed: August 20, 2025: https:\/\/aidsinfo.unaids.org\/.."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(22)00071-2","article-title":"Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis","volume":"6","author":"Wedderburn CJ","year":"2022","unstructured":"Wedderburn CJ, Weldon E, Bertran-Cobo C, et al.. Early neurodevelopment of HIV-exposed uninfected children in the era of antiretroviral therapy: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022, 6:393-408. 10.1016\/S2352-4642(22)00071-2","journal-title":"Lancet Child Adolesc Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003409","article-title":"Children who are HIV-exposed and uninfected: evidence for action","volume":"37","author":"Prendergast AJ","year":"2023","unstructured":"Prendergast AJ, Evans C. Children who are HIV-exposed and uninfected: evidence for action. AIDS. 2023, 37:205-15. 10.1097\/QAD.0000000000003409","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/v15020279","article-title":"Immune and metabolic alterations in children with perinatal HIV exposure","volume":"15","author":"du Toit LD","year":"2023","unstructured":"du Toit LD, Prinsloo A, Steel HC, Feucht U, Louw R, Rossouw TM. Immune and metabolic alterations in children with perinatal HIV exposure. Viruses. 2023, 15:9. 10.3390\/v15020279","journal-title":"Viruses"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-019-00459-0","article-title":"Growth and neurodevelopment of HIV-exposed uninfected children: a conceptual framework","volume":"16","author":"Wedderburn CJ","year":"2019","unstructured":"Wedderburn CJ, Evans C, Yeung S, Gibb DM, Donald KA, Prendergast AJ. Growth and neurodevelopment of HIV-exposed uninfected children: a conceptual framework. Curr HIV\/AIDS Rep. 2019, 16:501-13. 10.1007\/s11904-019-00459-0","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab030","article-title":"Cardiac remodeling and hypertension in HIV-uninfected infants exposed in utero to antiretroviral therapy","volume":"73","author":"Garc\u00eda-Otero L","year":"2021","unstructured":"Garc\u00eda-Otero L, L\u00f3pez M, Gonc\u00e9 A, et al.. Cardiac remodeling and hypertension in HIV-uninfected infants exposed in utero to antiretroviral therapy. Clin Infect Dis. 2021, 73:586-93. 10.1093\/cid\/ciab030","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12695","article-title":"Mortality risk and associated factors in HIV-exposed, uninfected children","volume":"21","author":"Arikawa S","year":"2016","unstructured":"Arikawa S, Rollins N, Newell ML, Becquet R. Mortality risk and associated factors in HIV-exposed, uninfected children. Trop Med Int Health. 2016, 21:720-34. 10.1111\/tmi.12695","journal-title":"Trop Med Int Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2022.2141185","article-title":"Psychiatric disorders in perinatally HIV-exposed, uninfected children: a systematic review","volume":"36","author":"Ameri S","year":"2024","unstructured":"Ameri S, Moseholm E, Weis N. Psychiatric disorders in perinatally HIV-exposed, uninfected children: a systematic review. AIDS Care. 2024, 36:70-9. 10.1080\/09540121.2022.2141185","journal-title":"AIDS Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003039","article-title":"Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed","volume":"35","author":"Anderson K","year":"2021","unstructured":"Anderson K, Kalk E, Madlala HP, et al.. Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed. AIDS. 2021, 35:2327-39. 10.1097\/QAD.0000000000003039","journal-title":"AIDS"},{"key":"ref14","unstructured":"UNAIDS. AIDS and the sustainable development goals. (2025). Accessed: August 20, 2025: https:\/\/www.unaids.org\/en\/AIDS_SDGs."},{"key":"ref15","unstructured":"United Nations. Sustainable Development Goals. (2025). Accessed: August 20, 2025: https:\/\/www.un.org\/sustainabledevelopment\/."},{"key":"ref16","unstructured":"UNAIDS. The Global Alliance to End AIDS in Children. (2025). Accessed: August 20, 2025: https:\/\/www.childrenandaids.org\/node\/1526."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.09.040","article-title":"High burden of morbidity and mortality but not growth failure in infants exposed to but uninfected with human immunodeficiency virus in Tanzania","volume":"180","author":"Locks LM","year":"2017","unstructured":"Locks LM, Manji KP, Kupka R, et al.. High burden of morbidity and mortality but not growth failure in infants exposed to but uninfected with human immunodeficiency virus in Tanzania. J Pediatr. 2017, 180:191-9.e2. 10.1016\/j.jpeds.2016.09.040","journal-title":"J Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001574","article-title":"Child growth according to maternal and child HIV status in Zimbabwe","volume":"36","author":"Omoni AO","year":"2017","unstructured":"Omoni AO, Ntozini R, Evans C, Prendergast AJ, Moulton LH, Christian PS, Humphrey JH. Child growth according to maternal and child HIV status in Zimbabwe. Pediatr Infect Dis J. 2017, 36:869-76. 10.1097\/INF.0000000000001574","journal-title":"Pediatr Infect Dis J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx187","article-title":"In utero ART exposure and birth and early growth outcomes among HIV-exposed uninfected infants attending immunization services: results from national PMTCT surveillance, South Africa","volume":"4","author":"Ramokolo V","year":"2017","unstructured":"Ramokolo V, Goga AE, Lombard C, Doherty T, Jackson DJ, Engebretsen IM. In utero ART exposure and birth and early growth outcomes among HIV-exposed uninfected infants attending immunization services: results from national PMTCT surveillance, South Africa. Open Forum Infect Dis. 2017, 4:7. 10.1093\/ofid\/ofx187","journal-title":"Open Forum Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002238","article-title":"Compromised growth among HIV-exposed uninfected compared with unexposed children in Nigeria","volume":"38","author":"Jumare J","year":"2019","unstructured":"Jumare J, Datong P, Osawe S, Okolo F, Mohammed S, Inyang B, Abimiku A. Compromised growth among HIV-exposed uninfected compared with unexposed children in Nigeria. Pediatr Infect Dis J. 2019, 38:280-6. 10.1097\/INF.0000000000002238","journal-title":"Pediatr Infect Dis J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.22-0482","article-title":"A 12-month prospective study of HIV-infected and HIV-uninfected women and their infants in Malawi: comparative analysis of clinical events and infant growth","volume":"108","author":"Floridia M","year":"2023","unstructured":"Floridia M, Orlando S, Andreotti M, et al.. A 12-month prospective study of HIV-infected and HIV-uninfected women and their infants in Malawi: comparative analysis of clinical events and infant growth. Am J Trop Med Hyg. 2023, 108:394-402. 10.4269\/ajtmh.22-0482","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(19)30007-0","article-title":"Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study","volume":"3","author":"le Roux SM","year":"2019","unstructured":"le Roux SM, Abrams EJ, Donald KA, et al.. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study. Lancet Child Adolesc Health. 2019, 3:234-44. 10.1016\/S2352-4642(19)30007-0","journal-title":"Lancet Child Adolesc Health"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003122","article-title":"Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age","volume":"36","author":"Fowler MG","year":"2022","unstructured":"Fowler MG, Aizire J, Sikorskii A, et al.. Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age. AIDS. 2022, 36:573-82. 10.1097\/QAD.0000000000003122","journal-title":"AIDS"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003124","article-title":"Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya","volume":"36","author":"Neary J","year":"2022","unstructured":"Neary J, Langat A, Singa B, et al.. Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya. AIDS. 2022, 36:605-10. 10.1097\/QAD.0000000000003124","journal-title":"AIDS"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix111","article-title":"Low birth weight in human immunodeficiency virus-exposed uninfected infants in Bronx, New York","volume":"7","author":"Dara JS","year":"2018","unstructured":"Dara JS, Hanna DB, Anastos K, Wright R, Herold BC. Low birth weight in human immunodeficiency virus-exposed uninfected infants in Bronx, New York. J Pediatric Infect Dis Soc. 2018, 7:e24-9. 10.1093\/jpids\/pix111","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/v16020313","article-title":"Metabolic alterations in mothers living with HIV and their HIV-exposed, uninfected infants","volume":"16","author":"du Toit LD","year":"2024","unstructured":"du Toit LD, Mason S, van Reenen M, Rossouw TM, Louw R. Metabolic alterations in mothers living with HIV and their HIV-exposed, uninfected infants. Viruses. 2024, 16:3. 10.3390\/v16020313","journal-title":"Viruses"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12476-z","article-title":"Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia","volume":"22","author":"Nyemba DC","year":"2022","unstructured":"Nyemba DC, Kalk E, Vinikoor MJ, et al.. Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia. BMC Public Health. 2022, 22:55. 10.1186\/s12889-021-12476-z","journal-title":"BMC Public Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.882468","article-title":"No difference in growth outcomes up to 24 months of age by duration of exposure to maternal antiretroviral therapy among children who are HIV-exposed and uninfected in Malawi","volume":"10","author":"Toledo G","year":"2022","unstructured":"Toledo G, Landes M, van Lettow M, Tippett Barr BA, Bailey H, Thorne C, Crichton S. No difference in growth outcomes up to 24 months of age by duration of exposure to maternal antiretroviral therapy among children who are HIV-exposed and uninfected in Malawi. Front Pediatr. 2022, 10:8. 10.3389\/fped.2022.882468","journal-title":"Front Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjnut.2022.11.010","article-title":"Body composition trajectories during the first 23 months of life differ by HIV exposure among infants in Western Kenya: a prospective study","volume":"153","author":"Rickman RR","year":"2023","unstructured":"Rickman RR, Lane CE, Collins SM, et al.. Body composition trajectories during the first 23 months of life differ by HIV exposure among infants in Western Kenya: a prospective study. J Nutr. 2023, 153:331-9. 10.1016\/j.tjnut.2022.11.010","journal-title":"J Nutr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09051-3","article-title":"Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24\u00a0months of life in Western Kenya","volume":"24","author":"Ray JE","year":"2024","unstructured":"Ray JE, Dobbs KR, Ogolla SO, et al.. Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24\u00a0months of life in Western Kenya. BMC Infect Dis. 2024, 24:156. 10.1186\/s12879-024-09051-3","journal-title":"BMC Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002754","article-title":"Risk and rates of hospitalisation in young children: a prospective study of a South African birth cohort","volume":"4","author":"Wedderburn CJ","year":"2024","unstructured":"Wedderburn CJ, Bondar J, Lake MT, et al.. Risk and rates of hospitalisation in young children: a prospective study of a South African birth cohort. PLOS Glob Public Health. 2024, 4:e0002754. 10.1371\/journal.pgph.0002754","journal-title":"PLOS Glob Public Health"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032677","article-title":"Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children","volume":"102","author":"Awadu JE","year":"2023","unstructured":"Awadu JE, Zalwango SK, Sikorskii A, Giordani B, Bovin MJ, Musoke PM, Ezeamama AE. Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children. Medicine (Baltimore). 2023, 102:e32677. 10.1097\/MD.0000000000032677","journal-title":"Medicine (Baltimore)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26152","article-title":"Children of a syndemic: co-occurring and mutually reinforcing adverse child health exposures in a prospective cohort of HIV-affected mother-infant dyads in Cape Town, South Africa","volume":"26 Suppl 4","author":"le Roux SM","year":"2023","unstructured":"le Roux SM, Abrams EJ, Zerbe A, Phillips TK, Myer L. Children of a syndemic: co-occurring and mutually reinforcing adverse child health exposures in a prospective cohort of HIV-affected mother-infant dyads in Cape Town, South Africa. J Int AIDS Soc. 2023, 26 Suppl 4:e26152. 10.1002\/jia2.26152","journal-title":"J Int AIDS Soc"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12978-016-0149-5","article-title":"Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis","volume":"13","author":"Mesfin YM","year":"2016","unstructured":"Mesfin YM, Kibret KT, Taye A. Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis. Reprod Health. 2016, 13:30. 10.1186\/s12978-016-0149-5","journal-title":"Reprod Health"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(94)00365-K","article-title":"Fetal growth and the etiology of preterm delivery","volume":"85","author":"Hediger ML","year":"1995","unstructured":"Hediger ML, Scholl TO, Schall JI, Miller LW, Fischer RL. Fetal growth and the etiology of preterm delivery. Obstet Gynecol. 1995, 85:175-82. 10.1016\/0029-7844(94)00365-K","journal-title":"Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00314-7","article-title":"Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010\/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"397","author":"Lockman S","year":"2021","unstructured":"Lockman S, Brummel SS, Ziemba L, et al.. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010\/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021, 397:1276-92. 10.1016\/S0140-6736(21)00314-7","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1037\/a0032694","article-title":"A pandemic of the poor: social disadvantage and the U.S. HIV epidemic","volume":"68","author":"Pellowski JA","year":"2013","unstructured":"Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013, 68:197-209. 10.1037\/a0032694","journal-title":"Am Psychol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.697091","article-title":"Neurodevelopmental outcomes of young children born to HIV-infected mothers: a pilot study","volume":"9","author":"McHenry MS","year":"2021","unstructured":"McHenry MS, Oyungu E, Yang Z, Ombitsa AR, Cherop C, Vreeman RC. Neurodevelopmental outcomes of young children born to HIV-infected mothers: a pilot study. Front Pediatr. 2021, 9:697091. 10.3389\/fped.2021.697091","journal-title":"Front Pediatr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2023.2240069","article-title":"Attention and neurodevelopment in young children who are HIV-exposed uninfected","volume":"36","author":"Young JM","year":"2024","unstructured":"Young JM, Chen V, Bitnun A, Read SE, Smith ML. Attention and neurodevelopment in young children who are HIV-exposed uninfected. AIDS Care. 2024, 36:26-35. 10.1080\/09540121.2023.2240069","journal-title":"AIDS Care"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.800273","article-title":"A neurometabolic pattern of elevated myo-inositol in children who are HIV-exposed and uninfected: a South African birth cohort study","volume":"13","author":"Bertran-Cobo C","year":"2022","unstructured":"Bertran-Cobo C, Wedderburn CJ, Robertson FC, et al.. A neurometabolic pattern of elevated myo-inositol in children who are HIV-exposed and uninfected: a South African birth cohort study. Front Immunol. 2022, 13:800273. 10.3389\/fimmu.2022.800273","journal-title":"Front Immunol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25863","article-title":"Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort","volume":"25","author":"Wedderburn CJ","year":"2022","unstructured":"Wedderburn CJ, Groenewold NA, Roos A, et al.. Early structural brain development in infants exposed to HIV and antiretroviral therapy in utero in a South African birth cohort. J Int AIDS Soc. 2022, 25:e25863. 10.1002\/jia2.25863","journal-title":"J Int AIDS Soc"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1251575","article-title":"(1)H-MRS neurometabolite profiles and motor development in school-aged children who are HIV-exposed uninfected: a birth cohort study","volume":"17","author":"Williams SR","year":"2023","unstructured":"Williams SR, Robertson FC, Wedderburn CJ, et al.. (1)H-MRS neurometabolite profiles and motor development in school-aged children who are HIV-exposed uninfected: a birth cohort study. Front Neurosci. 2023, 17:1251575. 10.3389\/fnins.2023.1251575","journal-title":"Front Neurosci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102505","article-title":"MRS suggests multi-regional inflammation and white matter axonal damage at 11\u00a0years following perinatal HIV infection","volume":"28","author":"Graham AS","year":"2020","unstructured":"Graham AS, Holmes MJ, Little F, et al.. MRS suggests multi-regional inflammation and white matter axonal damage at 11\u00a0years following perinatal HIV infection. Neuroimage Clin. 2020, 28:102505. 10.1016\/j.nicl.2020.102505","journal-title":"Neuroimage Clin"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2018.00145","article-title":"Perinatal HIV infection or exposure is associated with low N-acetylaspartate and glutamate in basal ganglia at age 9 but not 7 years","volume":"12","author":"Robertson FC","year":"2018","unstructured":"Robertson FC, Holmes MJ, Cotton MF, et al.. Perinatal HIV infection or exposure is associated with low N-acetylaspartate and glutamate in basal ganglia at age 9 but not 7 years. Front Hum Neurosci. 2018, 12:145. 10.3389\/fnhum.2018.00145","journal-title":"Front Hum Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26165","article-title":"Lower academic performance among children with perinatal HIV exposure in Botswana","volume":"26","author":"Powis KM","year":"2023","unstructured":"Powis KM, Lebanna L, Schenkel S, et al.. Lower academic performance among children with perinatal HIV exposure in Botswana. J Int AIDS Soc. 2023, 26:e26165. 10.1002\/jia2.26165","journal-title":"J Int AIDS Soc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001683","article-title":"Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial","volume":"32","author":"Boivin MJ","year":"2018","unstructured":"Boivin MJ, Barlow-Mosha L, Chernoff MC, et al.. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial. AIDS. 2018, 32:189-204. 10.1097\/QAD.0000000000001683","journal-title":"AIDS"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1088","article-title":"African multi-site 2-year neuropsychological study of school-age children perinatally infected, exposed, and unexposed to human immunodeficiency virus","volume":"71","author":"Boivin MJ","year":"2020","unstructured":"Boivin MJ, Chernoff M, Fairlie L, et al.. African multi-site 2-year neuropsychological study of school-age children perinatally infected, exposed, and unexposed to human immunodeficiency virus. Clin Infect Dis. 2020, 71:e105-14. 10.1093\/cid\/ciz1088","journal-title":"Clin Infect Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063725","article-title":"Developmental disorder probability scores at 6-18 years old in relation to in-utero\/peripartum antiretroviral drug exposure among Ugandan children","volume":"19","author":"Awadu JE","year":"2022","unstructured":"Awadu JE, Sikorskii A, Zalwango S, Coventry A, Giordani B, Ezeamama AE. Developmental disorder probability scores at 6-18 years old in relation to in-utero\/peripartum antiretroviral drug exposure among Ugandan children. Int J Environ Res Public Health. 2022, 19:5. 10.3390\/ijerph19063725","journal-title":"Int J Environ Res Public Health"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.08.021","article-title":"Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort","volume":"91","author":"Sevenoaks T","year":"2021","unstructured":"Sevenoaks T, Wedderburn CJ, Donald KA, Barnett W, Zar HJ, Stein DJ, Naud\u00e9 PJ. Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort. Brain Behav Immun. 2021, 91:65-73. 10.1016\/j.bbi.2020.08.021","journal-title":"Brain Behav Immun"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz351","article-title":"Maternal factors associated with infant neurodevelopment in HIV-exposed uninfected infants","volume":"6","author":"Alcaide ML","year":"2019","unstructured":"Alcaide ML, Rodriguez VJ, Abbamonte JM, et al.. Maternal factors associated with infant neurodevelopment in HIV-exposed uninfected infants. Open Forum Infect Dis. 2019, 6:1. 10.1093\/ofid\/ofz351","journal-title":"Open Forum Infect Dis"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002332","article-title":"In utero efavirenz exposure and neurodevelopmental outcomes in HIV-exposed uninfected children in Botswana","volume":"38","author":"Cassidy AR","year":"2019","unstructured":"Cassidy AR, Williams PL, Leidner J, et al.. In utero efavirenz exposure and neurodevelopmental outcomes in HIV-exposed uninfected children in Botswana. Pediatr Infect Dis J. 2019, 38:828-34. 10.1097\/INF.0000000000002332","journal-title":"Pediatr Infect Dis J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002550","article-title":"Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected","volume":"34","author":"Crowell CS","year":"2020","unstructured":"Crowell CS, Williams PL, Yildirim C, et al.. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected. AIDS. 2020, 34:1377-87. 10.1097\/QAD.0000000000002550","journal-title":"AIDS"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30340-6","article-title":"Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study","volume":"7","author":"Williams PL","year":"2020","unstructured":"Williams PL, Yildirim C, Chadwick EG, et al.. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study. Lancet HIV. 2020, 7:e49-58. 10.1016\/S2352-3018(19)30340-6","journal-title":"Lancet HIV"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001875","article-title":"Risk for speech and language impairments in preschool age HIV-exposed uninfected children with in utero combination antiretroviral exposure","volume":"37","author":"Rice ML","year":"2018","unstructured":"Rice ML, Russell JS, Frederick T, et al.. Risk for speech and language impairments in preschool age HIV-exposed uninfected children with in utero combination antiretroviral exposure. Pediatr Infect Dis J. 2018, 37:678-85. 10.1097\/INF.0000000000001875","journal-title":"Pediatr Infect Dis J"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26149","article-title":"Neurodevelopment of children who are HIV-exposed and uninfected in Kenya","volume":"26","author":"Bulterys MA","year":"2023","unstructured":"Bulterys MA, Njuguna I, King'e M, et al.. Neurodevelopment of children who are HIV-exposed and uninfected in Kenya. J Int AIDS Soc. 2023, 26:e26149. 10.1002\/jia2.26149","journal-title":"J Int AIDS Soc"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir837","article-title":"Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia","volume":"54","author":"Gompels UA","year":"2012","unstructured":"Gompels UA, Larke N, Sanz-Ramos M, et al.. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis. 2012, 54:434-42. 10.1093\/cid\/cir837","journal-title":"Clin Infect Dis"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1031924","article-title":"The adaptive immune system in early life: the shift makes it count","volume":"13","author":"Pieren DK","year":"2022","unstructured":"Pieren DK, Boer MC, de Wit J. The adaptive immune system in early life: the shift makes it count. Front Immunol. 2022, 13:4. 10.3389\/fimmu.2022.1031924","journal-title":"Front Immunol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac133","article-title":"Defective monocyte enzymatic function and an inhibitory immune phenotype in human immunodeficiency virus-exposed uninfected African infants in the era of antiretroviral therapy","volume":"226","author":"Afran L","year":"2022","unstructured":"Afran L, Jambo KC, Nedi W, et al.. Defective monocyte enzymatic function and an inhibitory immune phenotype in human immunodeficiency virus-exposed uninfected African infants in the era of antiretroviral therapy. J Infect Dis. 2022, 226:1243-55. 10.1093\/infdis\/jiac133","journal-title":"J Infect Dis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108427","article-title":"HIV-exposed uninfected infants' immune defects: from pathogen sensing, oxidative burst to antigens responses","volume":"26","author":"Djoba Siawaya JF","year":"2023","unstructured":"Djoba Siawaya JF, Maloupazoa Siawaya AC. HIV-exposed uninfected infants' immune defects: from pathogen sensing, oxidative burst to antigens responses. iScience. 2023, 26:108427. 10.1016\/j.isci.2023.108427","journal-title":"iScience"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00383","article-title":"The immune system of HIV-exposed uninfected infants","volume":"7","author":"Abu-Raya B","year":"2016","unstructured":"Abu-Raya B, Kollmann TR, Marchant A, MacGillivray DM. The immune system of HIV-exposed uninfected infants. Front Immunol. 2016, 7:383. 10.3389\/fimmu.2016.00383","journal-title":"Front Immunol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002128","article-title":"HIV-exposed-uninfected infants have increased inflammation and monocyte activation","volume":"33","author":"Dirajlal-Fargo S","year":"2019","unstructured":"Dirajlal-Fargo S, Mussi-Pinhata MM, Weinberg A, et al.. HIV-exposed-uninfected infants have increased inflammation and monocyte activation. AIDS. 2019, 33:845-53. 10.1097\/QAD.0000000000002128","journal-title":"AIDS"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0206-5","article-title":"HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort","volume":"7","author":"Lohman-Payne B","year":"2018","unstructured":"Lohman-Payne B, Gabriel B, Park S, et al.. HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med. 2018, 7:26. 10.1186\/s40169-018-0206-5","journal-title":"Clin Transl Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946201759030","article-title":"Immune development in HIV-exposed uninfected children born to HIV-infected women","volume":"59","author":"Miyamoto M","year":"2017","unstructured":"Miyamoto M, Gouv\u00eaa AF, Ono E, Succi RC, Pahwa S, Moraes-Pinto MI. Immune development in HIV-exposed uninfected children born to HIV-infected women. Rev Inst Med Trop Sao Paulo. 2017, 59:e30. 10.1590\/S1678-9946201759030","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1533003","article-title":"Gut microbiota and other factors associated with increased T cell regulation in HIV-exposed uninfected infants","volume":"16","author":"Johnson MJ","year":"2025","unstructured":"Johnson MJ, Lazarus SK, Bennett AE, et al.. Gut microbiota and other factors associated with increased T cell regulation in HIV-exposed uninfected infants. Front Immunol. 2025, 16:1533003. 10.3389\/fimmu.2025.1533003","journal-title":"Front Immunol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00595","article-title":"HIV-exposed uninfected infants have increased regulatory T cells that correlate with decreased T cell function","volume":"10","author":"Jalbert E","year":"2019","unstructured":"Jalbert E, Williamson KM, Kroehl ME, et al.. HIV-exposed uninfected infants have increased regulatory T cells that correlate with decreased T cell function. Front Immunol. 2019, 10:595. 10.3389\/fimmu.2019.00595","journal-title":"Front Immunol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmz022","article-title":"Immune activation and microbial translocation markers in HIV-exposed uninfected Malawian infants in the first year of life","volume":"65","author":"Baroncelli S","year":"2019","unstructured":"Baroncelli S, Galluzzo CM, Liotta G, et al.. Immune activation and microbial translocation markers in HIV-exposed uninfected Malawian infants in the first year of life. J Trop Pediatr. 2019, 65:617-25. 10.1093\/tropej\/fmz022","journal-title":"J Trop Pediatr"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2019.1668535","article-title":"Psychiatric disorders and young adult milestones in HIV-exposed, uninfected youth","volume":"32","author":"Bucek A","year":"2020","unstructured":"Bucek A, Mellins CA, Leu CS, Dolezal C, Korich R, Wiznia A, Abrams EJ. Psychiatric disorders and young adult milestones in HIV-exposed, uninfected youth. AIDS Care. 2020, 32:420-8. 10.1080\/09540121.2019.1668535","journal-title":"AIDS Care"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002443","article-title":"Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy","volume":"34","author":"Lipshultz SE","year":"2020","unstructured":"Lipshultz SE, Sasaki N, Thompson B, et al.. Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy. AIDS. 2020, 34:529-37. 10.1097\/QAD.0000000000002443","journal-title":"AIDS"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002018","article-title":"A comparison of metabolic outcomes between obese HIV-exposed uninfected youth from the PHACS SMARTT study and HIV-unexposed youth from the NHANES study in the United States","volume":"81","author":"Jao J","year":"2019","unstructured":"Jao J, Jacobson DL, Yu W, et al.. A comparison of metabolic outcomes between obese HIV-exposed uninfected youth from the PHACS SMARTT study and HIV-unexposed youth from the NHANES study in the United States. J Acquir Immune Defic Syndr. 2019, 81:319-27. 10.1097\/QAI.0000000000002018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-019-03477-7","article-title":"Myocardial peak systolic velocity-a tool for cardiac screening of HIV-exposed uninfected children","volume":"179","author":"Martins P","year":"2020","unstructured":"Martins P, Pires A, Albuquerque ME, Oliveira-Santos M, Santos J, Sena C, Sei\u00e7a R. Myocardial peak systolic velocity-a tool for cardiac screening of HIV-exposed uninfected children. Eur J Pediatr. 2020, 179:395-404. 10.1007\/s00431-019-03477-7","journal-title":"Eur J Pediatr"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002444","article-title":"Impact of HIV and antiretroviral drug exposure on lung growth and function over 2 years in an African Birth Cohort","volume":"34","author":"Gray DM","year":"2020","unstructured":"Gray DM, Wedderburn CJ, MacGinty RP, et al.. Impact of HIV and antiretroviral drug exposure on lung growth and function over 2 years in an African Birth Cohort. AIDS. 2020, 34:549-58. 10.1097\/QAD.0000000000002444","journal-title":"AIDS"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02969-6","article-title":"The effects of exposure to HIV in neonates at a referral hospital in South Africa","volume":"21","author":"Mellqvist H","year":"2021","unstructured":"Mellqvist H, Saggers RT, Elfvin A, Hentz E, Ballot DE. The effects of exposure to HIV in neonates at a referral hospital in South Africa. BMC Pediatr. 2021, 21:485. 10.1186\/s12887-021-02969-6","journal-title":"BMC Pediatr"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002235","article-title":"Association of in utero HIV exposure with obesity and reactive airway disease in HIV-negative adolescents and young adults","volume":"83","author":"Fourman LT","year":"2020","unstructured":"Fourman LT, Pan CS, Zheng I, et al.. Association of in utero HIV exposure with obesity and reactive airway disease in HIV-negative adolescents and young adults. J Acquir Immune Defic Syndr. 2020, 83:126-34. 10.1097\/QAI.0000000000002235","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac416","article-title":"Lower insulin sensitivity in newborns with in utero HIV and antiretroviral exposure who are uninfected in Botswana","volume":"226","author":"Jao J","year":"2022","unstructured":"Jao J, Sun S, Bonner LB, et al.. Lower insulin sensitivity in newborns with in utero HIV and antiretroviral exposure who are uninfected in Botswana. J Infect Dis. 2022, 226:2002-9. 10.1093\/infdis\/jiac416","journal-title":"J Infect Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00338","article-title":"Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns","volume":"7","author":"Abu-Raya B","year":"2016","unstructured":"Abu-Raya B, Smolen KK, Willems F, Kollmann TR, Marchant A. Transfer of maternal antimicrobial immunity to HIV-exposed uninfected newborns. Front Immunol. 2016, 7:338. 10.3389\/fimmu.2016.00338","journal-title":"Front Immunol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2842773\/v1","article-title":"Feasibility study of a powder-based supplement intervention for a future synbiotic trial in breastfed children from South Africa","volume":"7","author":"Shivakoti R","year":"2023","unstructured":"Shivakoti R, Laughton B, Shafiq M, et al.. Feasibility study of a powder-based supplement intervention for a future synbiotic trial in breastfed children from South Africa. Res Sq. 2023, 7:3. 10.21203\/rs.3.rs-2842773\/v1","journal-title":"Res Sq"},{"key":"ref77","unstructured":"NIH Reporter. Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV. a randomized, placebo-controlled, double-blind trial. (2025). Accessed: August 20, 2025: https:\/\/reporter.nih.gov\/search\/UTfuCCsrfUmwM-0_cbGGeQ\/project-details\/10838355."},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001211","article-title":"A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children","volume":"30","author":"Brennan AT","year":"2016","unstructured":"Brennan AT, Bonawitz R, Gill CJ, et al.. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS. 2016, 30:2351-60. 10.1097\/QAD.0000000000001211","journal-title":"AIDS"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003365","article-title":"Higher hospitalization rates in children born HIV-exposed uninfected in British Columbia, Canada, between 1990 and 2012","volume":"41","author":"Li SN","year":"2022","unstructured":"Li SN, Albert A, Piske M, et al.. Higher hospitalization rates in children born HIV-exposed uninfected in British Columbia, Canada, between 1990 and 2012. Pediatr Infect Dis J. 2022, 41:124-30. 10.1097\/INF.0000000000003365","journal-title":"Pediatr Infect Dis J"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz820","article-title":"Rates of hospitalization and infection-related hospitalization among human immunodeficiency virus (HIV)-exposed uninfected children compared to HIV-unexposed uninfected children in the United States, 2007-2016","volume":"71","author":"Labuda SM","year":"2020","unstructured":"Labuda SM, Huo Y, Kacanek D, et al.. Rates of hospitalization and infection-related hospitalization among human immunodeficiency virus (HIV)-exposed uninfected children compared to HIV-unexposed uninfected children in the United States, 2007-2016. Clin Infect Dis. 2020, 71:332-9. 10.1093\/cid\/ciz820","journal-title":"Clin Infect Dis"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1102","article-title":"Contribution of maternal antiretroviral therapy and breastfeeding to 24-month survival in human immunodeficiency virus-exposed uninfected children: an individual pooled analysis of African and Asian studies","volume":"66","author":"Arikawa S","year":"2018","unstructured":"Arikawa S, Rollins N, Jourdain G, et al.. Contribution of maternal antiretroviral therapy and breastfeeding to 24-month survival in human immunodeficiency virus-exposed uninfected children: an individual pooled analysis of African and Asian studies. Clin Infect Dis. 2018, 66:1668-77. 10.1093\/cid\/cix1102","journal-title":"Clin Infect Dis"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002511","article-title":"Predictors of mortality among HIV-exposed infants through 18 months of age in Kenya: a retrospective review of programmatic data","volume":"39","author":"Sandbulte MR","year":"2020","unstructured":"Sandbulte MR, Nazir N, Goggin K, et al.. Predictors of mortality among HIV-exposed infants through 18 months of age in Kenya: a retrospective review of programmatic data. Pediatr Infect Dis J. 2020, 39:134-6. 10.1097\/INF.0000000000002511","journal-title":"Pediatr Infect Dis J"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12716","article-title":"Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa","volume":"21","author":"le Roux SM","year":"2016","unstructured":"le Roux SM, Abrams EJ, Nguyen K, Myer L. Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa. Trop Med Int Health. 2016, 21:829-45. 10.1111\/tmi.12716","journal-title":"Trop Med Int Health"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(19)30375-X","article-title":"Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study","volume":"4","author":"le Roux SM","year":"2020","unstructured":"le Roux SM, Abrams EJ, Donald KA, et al.. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study. Lancet Child Adolesc Health. 2020, 4:220-31. 10.1016\/S2352-4642(19)30375-X","journal-title":"Lancet Child Adolesc Health"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmu045","article-title":"Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration","volume":"60","author":"Marquez C","year":"2014","unstructured":"Marquez C, Okiring J, Chamie G, et al.. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr. 2014, 60:434-41. 10.1093\/tropej\/fmu045","journal-title":"J Trop Pediatr"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101356","article-title":"Body mass index in adolescence, risk of type 2 diabetes and associated complications: a nationwide cohort study of men","volume":"46","author":"Karin A","year":"2022","unstructured":"Karin A, Jon E, Martin A, et al.. Body mass index in adolescence, risk of type 2 diabetes and associated complications: a nationwide cohort study of men. EClinicalMedicine. 2022, 46:101356. 10.1016\/j.eclinm.2022.101356","journal-title":"EClinicalMedicine"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001318","article-title":"Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al","volume":"31","author":"Brennan AT","year":"2017","unstructured":"Brennan AT, Bonawitz R, Gill CJ, Thea DM, Long L, Fox MP. Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al. AIDS. 2017, 31:317. 10.1097\/QAD.0000000000001318","journal-title":"AIDS"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa","volume":"373","author":"Danel C","year":"2015","unstructured":"Danel C, Moh R, Gabillard D, et al.. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015, 373:808-22. 10.1056\/NEJMoa1507198","journal-title":"N Engl J Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren JD","year":"2015","unstructured":"Lundgren JD, Babiker AG, Gordin F, et al.. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015, 373:795-807. 10.1056\/NEJMoa1506816","journal-title":"N Engl J Med"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00199","article-title":"The PHACS SMARTT study: assessment of the safety of in utero exposure to antiretroviral drugs","volume":"7","author":"Van Dyke RB","year":"2016","unstructured":"Van Dyke RB, Chadwick EG, Hazra R, Williams PL, Seage GR 3rd. The PHACS SMARTT study: assessment of the safety of in utero exposure to antiretroviral drugs. Front Immunol. 2016, 7:199. 10.3389\/fimmu.2016.00199","journal-title":"Front Immunol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070465","article-title":"Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study","volume":"13","author":"Slogrove AL","year":"2023","unstructured":"Slogrove AL, de Beer ST, Kalk E, et al.. Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study. BMJ Open. 2023, 13:e070465. 10.1136\/bmjopen-2022-070465","journal-title":"BMJ Open"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26160","article-title":"Strengthening the evidence to improve health outcomes of children with perinatal HIV exposure","volume":"26","author":"Lee S","year":"2023","unstructured":"Lee S, Allison S, Brouwers P. Strengthening the evidence to improve health outcomes of children with perinatal HIV exposure. J Int AIDS Soc. 2023, 26:e26160. 10.1002\/jia2.26160","journal-title":"J Int AIDS Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/423630-health-disparities-among-children-who-are-hiv-exposed-but-without-hiv-a-narrative-literature-review-and-call-to-action-for-further-research","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:24:12Z","timestamp":1766157852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/423630-health-disparities-among-children-who-are-hiv-exposed-but-without-hiv-a-narrative-literature-review-and-call-to-action-for-further-research"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":92,"URL":"https:\/\/doi.org\/10.7759\/cureus.99628","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}